Results 81 to 90 of about 19,951 (230)
Treatment Selection and Prioritization for the EJS ACT‐PD MAMS Trial Platform
Abstract Background There are currently no disease‐modifying therapies (DMTs) registered for Parkinson's disease (PD). The Edmond J. Safra Accelerating Clinical Trials in Parkinson Disease (EJS ACT‐PD) initiative will expedite clinical assessment of putative DMTs through a multi‐arm multistage (MAMS) trial, testing several treatments against a common ...
Cristina Gonzalez‐Robles+29 more
wiley +1 more source
Structure and regulation of desmosomes in intercalated discs: Lessons from epithelia
Adrenergic agonists act via PKA‐dependent PG phosphorylation at S665, leading to enhanced translocation of DSG2 to the desmosomes or area composita of the ICD and thereby increasing cardiomyocyte adhesion. On the other hand adrenergic agonists, PKC activation by PMA ,p38MAPK inhibition by SB202190 and digitoxin enhanced cardiomyocyte adhesion, in an ...
Sunil Yeruva, Jens Waschke
wiley +1 more source
Light‐Activated Pharmacological Tools for Exploring the Cholinergic System
ABSTRACT Cholinergic transmission plays a critical role in both the central and peripheral nervous systems, affecting processes such as learning, memory, and inflammation. Conventional cholinergic drugs generally suffer from poor selectivity and temporal precision, leading to undesired effects and limited therapeutic efficacy. Photopharmacology aims to
Alessio Colleoni+5 more
wiley +1 more source
Background: Serum soluble ST2 (sST2) levels are elevated early after acute myocardial infarction and are related to adverse left ventricular (LV) remodeling and cardiovascular outcomes in ST-segment elevation myocardial infarction (STEMI). Beta-blockers (
Wei-Ping Huang+5 more
doaj +1 more source
Recent Developments in the Optical Control of Adrenergic Signaling
ABSTRACT Adrenoceptors (ARs) play a vital role in various physiological processes and are key therapeutic targets. The advent of optical control techniques, including optogenetics and photopharmacology, offers the potential to modulate AR signaling with precise temporal and spatial resolution. In this review, we summarize the latest advancements in the
Shuang Shi+4 more
wiley +1 more source
Pathophysiology of Urethral Instability: Dysfunction of Smooth Urethral Musculature
ABSTRACT Aims The aim of this study is to elucidate the pathophysiological mechanisms of urethral instability by analyzing and comparing cystometric data from a female individual with urethral instability and another with normal micturition. Methods Data were collected from a previous study measuring urethral pressure at three distinct points within ...
Pieter L. Venema+4 more
wiley +1 more source
β3‐Adrenoceptor Agonist Effects on the Urinary Bladder Beyond Detrusor Relaxation
ABSTRACT Aims β3‐Adrenoceptor agonists such as mirabegron or vibegron reach pharmacokinetic steady‐state within a few days. However, maximum improvements in symptoms of the overactive bladder syndrome are reached at time points later than 4 weeks, that is, detrusor smooth muscle relaxation cannot fully explain clinical effects.
Martin C. Michel+2 more
wiley +1 more source
Is cognitive conflict really effortful? Conflict priming and shielding effects on cardiac response
Abstract Two experiments with N = 221 university students investigated the impact of primed cognitive conflict on effort assessed as cardiac response in tasks that were not conflict‐related themselves. Manifest cognitive conflict in cognitive control tasks is confounded with objective response difficulty (e.g., in incongruent Stroop task trials).
Yann S. Bouzidi, Guido H. E. Gendolla
wiley +1 more source
49 patients (28 female, 21 male) with implanted DDD/DDDR, VVI/VVIR and CRT pacemakers are investigated. Purpose frequency and dose rate of anticoagulants, antiplatelet agents, direct thrombin inhibitors, cardiac glycosides, amiodarone; ivabradine ...
M. S. Brynza, M. I. Yabluchansky
doaj
Cost-effectiveness of glaucoma management with monotherapy medications in Egypt
Glaucoma is a serious chronic ophthalmic disease since it causes irreversible visual disability if untreated can lead to blindness. Treatment options include medications (classified into five major classes of drugs which are muscarinic cholinergic ...
Amal Abd-Elaal El-Khamery+3 more
doaj +1 more source